Citations (49)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (20)
Corrado Pelaia, Anna Ferrante Bannera, Fioramante Lello Rotundo, Francesco Giuseppe Tropea, Giuseppe Armentaro, Angelantonio Maglio, Angela Sciacqua, Alessandro Vatrella & Girolamo Pelaia. (2023) Clinical and Functional Effects of Inhaled Dual Therapy Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease: A Real-Life Study. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 995-1002.
Read now
Read now
Cristoforo Incorvaia, Bruna L. Gritti & Erminia Ridolo. (2020) Is there any further advance in bronchodilator combination therapy for COPD?. Current Medical Research and Opinion 36:1, pages 125-126.
Read now
Read now
Birsen Pinar Yildiz, Mesut Bayraktaroglu & Hakan Gunen. (2019) Bronchodilator efficacy of tiotropium/formoterol (18/12 µg once daily via a Discair inhaler), tiotropium alone (18 µg by Handihaler) or combined with formoterol (12 µg twice daily by Aerolizer) in adults with moderate-to-severe stable COPD. Current Medical Research and Opinion 35:12, pages 2187-2196.
Read now
Read now
Fabiano Di Marco, Piero Balbo, Francesco de Blasio, Vittorio Cardaci, Nunzio Crimi, Giuseppe Girbino, Girolamo Pelaia, Pietro Pirina, Pietro Roversi, Pierachille Santus, Nicola Scichilone, Alessandro Vatrella, Patrizio Pasqualetti & Mauro Carone. (2019) Early management of COPD: where are we now and where do we go from here? A Delphi consensus project. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 353-360.
Read now
Read now
Mario Malerba, Alessandro Radaeli, Paolo Montuschi, Kesavan S. Babu & Jaymin B Morjaria. (2017) Investigational beta-2 adrenergic agonists for the treatment of chronic obstructive pulmonary disease. Expert Opinion on Investigational Drugs 26:3, pages 319-329.
Read now
Read now
Maria Gabriella Matera, Alessandro Sanduzzi & Mario Cazzola. (2016) Specific role of combination aclidinium: formoterol in the treatment of chronic obstructive pulmonary disease. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 73-79.
Read now
Read now
Reynold A Panettieri Jr. (2015) Bronchodilators, receptors and cross-talk: Together is better?. Postgraduate Medicine 127:7, pages 771-780.
Read now
Read now
Tony D’Urzo, James F Donohue, David Price, Marc Miravitlles & Edward Kerwin. (2015) Dual bronchodilator therapy with aclidinium bromide/formoterol fumarate for chronic obstructive pulmonary disease. Expert Review of Respiratory Medicine 9:5, pages 519-532.
Read now
Read now
James F Davidson, James F Donohue & Jill A Ohar. (2015) Umeclidinium/vilanterol combination inhaler efficacy and potential impact on current chronic obstructive pulmonary disease management guidelines. Expert Opinion on Drug Safety 14:2, pages 317-324.
Read now
Read now
Maria Gabriella Matera, Paola Rogliani & Mario Cazzola. (2014) Muscarinic receptor antagonists for the treatment of chronic obstructive pulmonary disease. Expert Opinion on Pharmacotherapy 15:7, pages 961-977.
Read now
Read now
Annette J Theron, Helen C Steel, Gregory R Tintinger, Charles Feldman & Ronald Anderson. (2013) Can the anti-inflammatory activities of β2-agonists be harnessed in the clinical setting?. Drug Design, Development and Therapy 7, pages 1387-1398.
Read now
Read now
Mario Cazzola, Andrea Segreti & Maria Gabriella Matera. (2013) New developments in the combination treatment of COPD: focus on umeclidinium/vilanterol. Drug Design, Development and Therapy 7, pages 1201-1208.
Read now
Read now
Ronald Dahl, Dalal Jadayel, Vijay KT Alagappan, Hungta Chen & Donald Banerji. (2013) Efficacy and safety of QVA149 compared to the concurrent administration of its monocomponents indacaterol and glycopyrronium: the BEACON study. International Journal of Chronic Obstructive Pulmonary Disease 8, pages 501-508.
Read now
Read now
Mario Cazzola, Paola Rogliani & Maria Gabriella Matera. (2013)
Aclidinium bromide/formoterol fumarate fixed-dose combination for the treatment of chronic obstructive pulmonary disease. Expert Opinion on Pharmacotherapy 14:6, pages 775-781.
Read now
Read now
Vandana Gupta & Dave Singh. (2012) Aclidinium bromide for the treatment of chronic obstructive pulmonary disease. Expert Review of Respiratory Medicine 6:6, pages 581-588.
Read now
Read now
Jutta Beier, Jan van Noord, Amanda Deans, Jean Brooks, Claire Maden, Suus Baggen, Rashmi Mehta & Anthony Cahn. (2012) Safety and efficacy of dual therapy with GSK233705 and salmeterol versus monotherapy with salmeterol, tiotropium, or placebo in a crossover pilot study in partially reversible COPD patients. International Journal of Chronic Obstructive Pulmonary Disease 7, pages 153-164.
Read now
Read now
Donald P Tashkin. (2010) Indacaterol maleate for the treatment of chronic obstructive pulmonary disease. Expert Opinion on Pharmacotherapy 11:12, pages 2077-2085.
Read now
Read now
Donald P Tashkin. (2010) Preventing and managing exacerbations in COPD – critical appraisal of the role of tiotropium. International Journal of Chronic Obstructive Pulmonary Disease 5, pages 41-53.
Read now
Read now
Nicholas J Gross & James F Donohue. (2010) Nebulized formoterol: a review of clinical efficacy and safety in COPD. International Journal of Chronic Obstructive Pulmonary Disease 5, pages 223-232.
Read now
Read now
Mario Cazzola, Nicola A Hanania & Maria G Matera. (2010) Arformoterol tartrate in the treatment of COPD. Expert Review of Respiratory Medicine 4:2, pages 155-162.
Read now
Read now
Articles from other publishers (29)
Corrado Pelaia, Giada Procopio, Fioramante Lello Rotundo, Maria Rosaria Deodato, Anna Ferrante Bannera, Francesco Giuseppe Tropea, Anna Cancelliere, Alessandro Vatrella & Girolamo Pelaia. (2023) Real-life therapeutic effects of beclomethasone dipropionate/formoterol fumarate/glycopyrronium combined triple therapy in patients with chronic obstructive pulmonary disease. Therapeutic Advances in Respiratory Disease 17, pages 175346662311557.
Crossref
Crossref
Elena Menchi, Charaf El Khattabi, Stéphanie Pochet, Olivier Denis, Karim Amighi & Nathalie Wauthoz. (2022) Optimization of Long-Acting Bronchodilator Dose Ratios Using Isolated Guinea Pig Tracheal Rings for Synergistic Combination Therapy in Asthma and COPD. Pharmaceuticals 15:8, pages 963.
Crossref
Crossref
Sahar Zayed, Fatma Fouad & Fathalla Belal. (2020) A simple and economic chromatographic method for simultaneous determination of six bronchodilator drugs in pharmaceutical dosage forms. Journal of the Iranian Chemical Society 18:6, pages 1251-1259.
Crossref
Crossref
Corrado Pelaia, Giada Procopio, Maria Rosaria Deodato, Olivia Florio, Angelantonio Maglio, Angela Sciacqua, Alessandro Vatrella & Girolamo Pelaia. (2021) Real-Life Clinical and Functional Effects of Fluticasone Furoate/Umeclidinium/Vilanterol-Combined Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease. Respiration 100:2, pages 127-134.
Crossref
Crossref
Ilaria Aredano, Francesca De Blasio, Paola Berchialla, Luisa Brussino, Caterina Bucca & Paolo Solidoro. (2020) <b>RETRACTED:</b> Determinants of self-reported adherence to inhaler therapy in patients with chronic obstructive pulmonary disease. Multidisciplinary Respiratory Medicine 15.
Crossref
Crossref
Bartolome R. Celli. (2018) Pharmacological Therapy of COPD. Chest 154:6, pages 1404-1415.
Crossref
Crossref
Anthony D'Urzo, Stephen Rennard, Edward Kerwin, James F. Donohue, Alejhandra Lei, Eduard Molins & Anne Leselbaum. (2017) A randomised double-blind, placebo-controlled, long-term extension study of the efficacy, safety and tolerability of fixed-dose combinations of aclidinium/formoterol or monotherapy in the treatment of chronic obstructive pulmonary disease. Respiratory Medicine 125, pages 39-48.
Crossref
Crossref
Dave Singh, Marc Miravitlles & Claus Vogelmeier. (2016) Chronic Obstructive Pulmonary Disease Individualized Therapy: Tailored Approach to Symptom Management. Advances in Therapy 34:2, pages 281-299.
Crossref
Crossref
Takashige Kuraki. 2017. Chronic Obstructive Pulmonary Disease. Chronic Obstructive Pulmonary Disease
211
243
.
Donald P. Tashkin, Fernando J. Martinez, Roberto Rodriguez-Roisin, Charles Fogarty, Mark Gotfried, Michael Denenberg, Gregory Gottschlich, James F. Donohue, Chad Orevillo, Patrick Darken, Earl St Rose, Shannon Strom, Tracy Fischer, Michael Golden & Colin Reisner. (2016) A multicenter, randomized, double-blind dose-ranging study of glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler compared to the monocomponents and open-label tiotropium dry powder inhaler in patients with moderate-to-severe COPD. Respiratory Medicine 120, pages 16-24.
Crossref
Crossref
Alexander I. Sinopal’nikov, I. V. Leshenko & K. Kostikas. (2016) The possibilities and limits of modern bronchodilating therapy for COPD. Clinical Medicine (Russian Journal) 94:6, pages 418-427.
Crossref
Crossref
Eva Rahman Kabir & Nabila Morshed. (2015) Different approaches in the treatment of obstructive pulmonary diseases. European Journal of Pharmacology 764, pages 306-317.
Crossref
Crossref
Mario Cazzola, Luigino Calzetta, Clive P. Page, Paola Rogliani, Francesco Facciolo, Amadeu Gavaldà & Maria Gabriella Matera. (2014) Pharmacological characterization of the interaction between aclidinium bromide and formoterol fumarate on human isolated bronchi. European Journal of Pharmacology 745, pages 135-143.
Crossref
Crossref
Philippa R Dale, Hana Cernecka, Martina Schmidt, Mark R Dowling, Steven J Charlton, Michael P Pieper & Martin C Michel. (2014) The pharmacological rationale for combining muscarinic receptor antagonists and β-adrenoceptor agonists in the treatment of airway and bladder disease. Current Opinion in Pharmacology 16, pages 31-42.
Crossref
Crossref
Makoto Hoshino & Junichi Ohtawa. (2014) Computed tomography assessment of airway dimensions with combined tiotropium and indacaterol therapy in COPD patients. Respirology 19:3, pages 403-410.
Crossref
Crossref
Sundeep Salvi, Bill Brashier, Dipti Gothi, Vinaya Karkhanis, Sapna Madas, Jaideep Gogtay & Jyotsna Joshi. (2014) Bronchodilator efficacy of tiotropium–formoterol via single pressurized meter dose inhaler (pMDI) versus tiotropium alone in COPD. Pulmonary Pharmacology & Therapeutics 27:1, pages 90-95.
Crossref
Crossref
Gregory J. Feldman & Anton Edin. (2013) The combination of umeclidinium bromide and vilanterol in the management of chronic obstructive pulmonary disease: current evidence and future prospects. Therapeutic Advances in Respiratory Disease 7:6, pages 311-319.
Crossref
Crossref
Mario Cazzola, Jose-Luis Lopez-Campos & Luis Puente-Maestu. (2013) The MABA approach: a new option to improve bronchodilator therapy. European Respiratory Journal 42:4, pages 885-887.
Crossref
Crossref
Mario Cazzola, Vito Brusasco, Stefano Centanni, Isa Cerveri, Fausto De Michele, Giuseppe Di Maria, Paolo Palange, Riccardo Pellegrino, Mario Polverino, Andrea Rossi & Alberto Papi. (2013) Project PriMo: Sharing principles and practices of bronchodilator therapy monitoring in COPD. Pulmonary Pharmacology & Therapeutics 26:2, pages 218-228.
Crossref
Crossref
Donald P Tashkin & Gary T Ferguson. (2013) Combination bronchodilator therapy in the management of chronic obstructive pulmonary disease. Respiratory Research 14:1, pages 49.
Crossref
Crossref
Stephane Jouneau, Arnaud Boché, Graziella Brinchault, Kristina Fekete, Stephanie Guillot, Sahar Bayat & Benoit Desrues. (2011) On-site screening of farming-induced chronic obstructive pulmonary disease with the use of an electronic mini-spirometer: results of a pilot study in Brittany, France. International Archives of Occupational and Environmental Health 85:6, pages 623-630.
Crossref
Crossref
Mario Cazzola, Clive P. Page, Luigino Calzetta & M. Gabriella Matera. (2012) Pharmacology and Therapeutics of Bronchodilators. Pharmacological Reviews 64:3, pages 450-504.
Crossref
Crossref
Wen‐Hui Zhang, Yong Zhang, Yong‐Yao Cui, Wei‐Fang Rong, Carole Cambier, Philippe Devillier, Fabrice Bureau, Charles Advenier & Pascal Gustin. (2011)
Can β
2
‐adrenoceptor agonists, anticholinergic drugs, and theophylline contribute to the control of pulmonary inflammation and emphysema in COPD?
. Fundamental & Clinical Pharmacology 26:1, pages 118-134.
Crossref
Crossref
Michael Roth. (2011) Is There a Regulatory Role of Immunoglobulins on Tissue Forming Cells Relevant in Chronic Inflammatory Lung Diseases?. Journal of Allergy 2011, pages 1-9.
Crossref
Crossref
Maria Gabriella Matera, Clive P. Page & Mario Cazzola. (2011) Novel bronchodilators for the treatment of chronic obstructive pulmonary disease. Trends in Pharmacological Sciences 32:8, pages 495-506.
Crossref
Crossref
Mario Cazzola, Luigino Calzetta & Maria Gabriella Matera. (2011) β2-adrenoceptor agonists: current and future direction. British Journal of Pharmacology 163:1, pages 4-17.
Crossref
Crossref
Mario Cazzola & Mathieu Molimard. (2010) The scientific rationale for combining long-acting β2-agonists and muscarinic antagonists in COPD. Pulmonary Pharmacology & Therapeutics 23:4, pages 257-267.
Crossref
Crossref
. (2010) Current World Literature. Current Opinion in Pulmonary Medicine 16:2, pages 162-167.
Crossref
Crossref
Donald P Tashkin. (2010) Long-acting anticholinergic use in chronic obstructive pulmonary disease: efficacy and safety. Current Opinion in Pulmonary Medicine 16:2, pages 97-105.
Crossref
Crossref